Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
- Status
- RECRUITING
- Phase
- PHASE1
Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
- Status
- RECRUITING
- Phase
- PHASE1
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
- Status
- RECRUITING
- Phase
- PHASE2
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE3
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
- Status
- RECRUITING
- Phase
- NA
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3